NCORP of the Carolinas (Greenville Health System NCORP)

项目摘要/摘要 卡罗莱纳州NCORP的定位是通过以下方式为癌症护理提供持续、强大的影响 在社区环境中进行研究。研究人员致力于改变当前的研究和临床实践 基于NCTN研究结果的范式。卡罗莱纳州NCORP的目标如下： 让社区肿瘤学家和其他医学专家参与NCTN癌症控制、预防和护理 分娩研究，以及嵌入治疗和成像研究的生活质量研究；提供 成人和儿科社区癌症控制、预防、治疗和护理提供试验机会； 吸引、招募和招募社区参与者，包括少数族裔、代表性不足和 服务不足的人群；确保所有符合条件的参与者都有机会进行生物质检 收集；向社会通报通过研究取得的进展；确保准确和及时的数据 提交和遵守协议；参与各自研究基地的概念开发 和确定社区差异的学习机会；加强和改善参与 通过将患者权益倡导者纳入研究概念和招募战略；以及指导 新的调查人员、合作伙伴和研究人员。 GHS(北部)和Palmetto Health System(中部)扩展为SC Health Company和 联合设施和资源充分支持未来的增长和应计项目 卡罗莱纳州癌症倡议。在GHS癌症中心，任何时候都有300多项临床试验在进行中 研究所，包括第一阶段、第二阶段、第三阶段治疗试验、预防试验、症状管理 试验和生活质量试验，所有这些都为患者提供了整个癌症过程中的最新技术 护理连续体。从预防到姑息治疗的各种研究产品确保患者 尽可能地接受最好的护理。新的研究举措包括最先进的分子遗传图谱 使患者能够留在集水区接受专门为其量身定做的尖端治疗 他们。数据管理对于癌症服务的临床和业务管理都很重要。 卡罗莱纳州的NCORP准备在NCORP任务的所有方面取得成功，并做出贡献 通过让患者参与并进行预期范围的临床试验，有意义地实现NCORP目标 和人类学科研究。

PROJECT SUMMARY/ABSTRACT NCORP of the Carolinas is positioned to provide a sustained, powerful influence on cancer care through research in the community setting. The investigators commit to shift current research and clinical practice paradigms based on the outcomes of NCTN research. The goals of NCORP of the Carolinas are as follows: to engage community oncologists and other medical specialists in NCTN cancer control, prevention, and care delivery research, as well as quality-of-life studies embedded within treatment and imaging studies; to offer the adult and pediatric communities cancer control, prevention, treatment and care delivery trial opportunities; to engage, recruit and enroll participants from the community inclusive of minorities, underrepresented, and underserved populations; to ensure all eligible participants are offered the opportunity for biospecimen collections; to inform the community of advances made through research; to assure accurate and timely data submission and protocol compliance; to participate with the respective research bases in concept development and identification of study opportunities for disparities in the community; to enhance and improve involvement of patient advocates by including advocates in research concepts and recruitment strategies; and to mentor new investigators, partners, and research staff. The expansion of GHS (Upstate) and Palmetto Health System (Midlands) into the SC Health Company and the joint facilities and resources more than adequately support future growth and accruals through NCORP of the Carolinas cancer initiatives. More than 300 clinical trials are active at any given time at the GHS Cancer Institute and include Phase I, Phase II, Phase III treatment trials, prevention trials, symptom management trials, and quality of life trials, all of which provide patients with the latest technology throughout their cancer care continuum. Research offerings across the spectrum from prevention to palliative care ensure patients receive the best care possible. New research initiatives include state-of-the-art genetic mapping for molecular targets that enable patients to stay in the catchment area for cutting-edge treatment tailored specifically to them. Data management is important to both the clinical and business management of cancer services. NCORP of the Carolinas is poised to succeed in all aspects of the NCORP mission and contribute meaningfully to the NCORP goals by engaging patients and conducting the anticipated range of clinical trials and human subject studies.